BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 34591891)

  • 1. On an ensemble algorithm for clustering cancer patient data.
    Qi R; Wu D; Sheng L; Henson D; Schwartz A; Xu E; Xing K; Chen D
    BMC Syst Biol; 2013; 7 Suppl 4(Suppl 4):S9. PubMed ID: 24565417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting determinants of prognosis in cutaneous melanoma.
    Weiss SA; Hanniford D; Hernando E; Osman I
    Cancer; 2015 Dec; 121(23):4108-23. PubMed ID: 26308244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk prediction for primary appendiceal cancer.
    Winicki NM; Radomski SN; Ciftci Y; Sabit AH; Johnston FM; Greer JB
    Surgery; 2024 Jun; 175(6):1489-1495. PubMed ID: 38494390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multigene prognostic signature associated with metastasis.
    Wang J; Harwood CA; Bailey E; Bewicke-Copley F; Anene CA; Thomson J; Qamar MJ; Laban R; Nourse C; Schoenherr C; Treanor-Taylor M; Healy E; Lai C; Craig P; Moyes C; Rickaby W; Martin J; Proby C; Inman GJ; Leigh IM
    J Am Acad Dermatol; 2023 Dec; 89(6):1159-1166. PubMed ID: 37586461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma.
    Podlipnik S; Martin BJ; Morgan-Linnell SK; Bailey CN; Siegel JJ; Petkov VI; Puig S
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cutaneous malignant melanoma patients' survival using deep learning: a retrospective cohort study.
    Cai S; Li W; Deng C; Tang Q; Zhou Z
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17103-17113. PubMed ID: 37755576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning identification of patient clusters for cutaneous melanoma.
    Thompson LJ; Furmanchuk A; Liszewski W; Kho A; West DP; Liebovitz DM; Nardone B; Gerami P
    Ital J Dermatol Venerol; 2023 Oct; 158(5):388-394. PubMed ID: 37750845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving five-year survival prediction via multitask learning across HPV-related cancers.
    Goncalves A; Soper B; Nygård M; Nygård JF; Ray P; Widemann D; Sales AP
    PLoS One; 2020; 15(11):e0241225. PubMed ID: 33196642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Cancer Survival Trends by Updated Summary Stage.
    Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics.
    Dhall A; Patiyal S; Kaur H; Bhalla S; Arora C; Raghava GPS
    Front Genet; 2020; 11():221. PubMed ID: 32273881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data.
    Arora C; Kaur D; Lathwal A; Raghava GPS
    Heliyon; 2020 Aug; 6(8):e04811. PubMed ID: 32913910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction to: Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
    Br J Dermatol; 2023 Oct; 189(5):e79. PubMed ID: 37621061
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary: 31-Gene Expression Profile Testing in Cutaneous Melanoma and Survival Outcomes in a Population-Based Analysis: A SEER Collaboration.
    Prieto PA
    J Clin Aesthet Dermatol; 2023 Dec; 16(12 Suppl 1):S9-S11. PubMed ID: 38125000
    [No Abstract]   [Full Text] [Related]  

  • 14. Current status of artificial intelligence methods for skin cancer survival analysis: a scoping review.
    Schreidah CM; Gordon ER; Adeuyan O; Chen C; Lapolla BA; Kent JA; Reynolds GB; Fahmy LM; Weng C; Tatonetti NP; Chase HS; Pe'er I; Geskin LJ
    Front Med (Lausanne); 2024; 11():1243659. PubMed ID: 38711781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating additional factors into the TNM staging for cutaneous melanoma by machine learning.
    Yang CQ; Wang H; Liu Z; Hueman MT; Bhaskaran A; Henson DE; Sheng L; Chen D
    PLoS One; 2021; 16(9):e0257949. PubMed ID: 34591891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding TNM for lung cancer through machine learning.
    Hueman M; Wang H; Liu Z; Henson D; Nguyen C; Park D; Sheng L; Chen D
    Thorac Cancer; 2021 May; 12(9):1423-1430. PubMed ID: 33713568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic system for epithelial ovarian carcinomas using machine learning.
    Grimley PM; Liu Z; Darcy KM; Hueman MT; Wang H; Sheng L; Henson DE; Chen D
    Acta Obstet Gynecol Scand; 2021 Aug; 100(8):1511-1519. PubMed ID: 33665831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the TNM for cancers of the colon and rectum using machine learning: a demonstration.
    Hueman M; Wang H; Henson D; Chen D
    ESMO Open; 2019; 4(3):e000518. PubMed ID: 31275615
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.